GRAFOTAS 50MG

Grafotas 50mg Capsule contains Cyclosporine as its active ingredient. This medication is classified as an immunosuppressant. Its primary purpose is to prevent organ rejection in patients who have received organ transplants, including kidney, liver, or heart transplants. It is often administered alongside other medications to help the body accept the new organ by suppressing the immune response. Following solid organ transplantation, the body tends to mount a strong immune reaction, identifying the transplanted organ’s antigens as foreign. Therefore, the use of immunosuppressive drugs is essential post-transplant to avert organ rejection.

Immunosuppressants can elevate the risk of skin cancer. It is advisable to minimize sun exposure, wear protective clothing, and apply sunscreen with a high SPF. Notify your doctor if you have recently received vaccinations with live vaccines. Grafotas 50mg Capsule is contraindicated in individuals with known hypersensitivity or allergies to this medication or its ingredients. This drug may also increase blood pressure. Caution is advised, or it should be avoided in patients with uncontrolled hypertension or a history of high blood pressure. It is crucial to discuss any potential reproductive effects with a healthcare provider, particularly for those planning to conceive. Monitoring for diabetes is also important, especially for individuals who are at risk.